The relation between homocysteine and calcific aortic valve stenosis

Cardiology

Volumn 103, Issue 4, 2005, Pages 207-211

  Gunduz, Huseyin ^a,c   Arinc, Huseyin ^a   Tamer, Ali ^a   Akdemir, Ramazan ^a   Ozhan, Hakan ^a   Binak, Emrah ^b   Uyan, Cihangir ^a  

^a ABANT IZZET BAYSAL UNIVERSITY   (Turkey)

^b SISLI ETFAL TRAINING AND RESEARCH HOSPITAL   (Turkey)

^c NONE   (Turkey)

Author keywords

Calcific aortic stenosis; Coronary artery disease; Homocysteine

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; HOMOCYSTEINE; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; AGED; AORTA VALVE STENOSIS; ARTICLE; BLOOD SAMPLING; COMPARATIVE STUDY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORRELATION ANALYSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STATISTICAL ANALYSIS;

AGE FACTORS; AGED; AORTIC VALVE STENOSIS; CALCINOSIS; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CORONARY DISEASE; DIABETES COMPLICATIONS; FEMALE; HOMOCYSTEINE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; RISK FACTORS; SMOKING; TRIGLYCERIDES;

EID: 21044444889     PISSN: 00086312     EISSN: None     Source Type: Journal    
DOI: 10.1159/000085199     Document Type: Article

References (22)

1. Agmon Y, Khandheria BK, Meissner I, Sicks JR, O'Fallon WM, Wiebers DO, Whisnant JP, Seward JB, Tajik AJ: Aortic valve sclerosis and aortic atherosclerosis: Different manifestations of the same disease? Insights from a population-based study. J Am Coll Cardiol 2001;38:827-834.
2. Novaro GM, Griffin BP: Calcific aortic stenosis: Another face of atherosclerosis? Cleve Clin J Med 2003;70:471-477.
3. Otto CM, Lind BK, Kilzman DW, Gersh BJ, Siscovick DS: Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly. N Engl J Med 1999;341:142-147.
4. Otto CM, O'Brien KD: Why is there discordance between calcific aortic stenosis and coronary artery disease? Heart 2001;85:601-602.
5. Kang SS, Wong PW, Malinow MR: Hyperhomocyst(e)inemia as risk factor for occlusive vascular disease. Annu Rev Nutr 1992;12:279-298.
6. Boushey CJ, Beresford SA, Omenn GS, Motulsky AG: A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA 1995;274:1049-1057.
7. Tawakol A, Omland T, Gerhard M, Wu JT, Creager MA: Hyperhomocyst(e)inemia is associated with impaired endothelium-dependent vasodilation in humans. Circulation 1997;95:1119-1121.
8. Tsai JC, Perrella MA, Yoshizumi M, Hsieh CM, Haber E, Schlegel R, Lee ME: Promotion of vascular smooth muscle cell growth by homocysteine: A link to atherosclerosis. Proc Natl Acad Sci USA 1994;91:6369-6373.
9. Poggianti E, Venneri L, Chubuchny V, Jambrik Z, Baroncini LA, Picano E: Aortic valve sclerosis is associated with systemic endothelial dysfunction. J Am Coll Cardiol 2003;41:136-141.
10. Novaro GM, Tiong IY, Pearce GL, Lauer MS, Sprecher DL, Griffin BP: Effect of hydroxymethylglutaryl coenzyme a reductase inhibitors on the progression of calcific aortic stenosis. Circulation 2001;104:2205-2209.
11. Novaro GM, Aronow HD, Mayer Sabik E, Griffin BP: Is plasma homocysteine associated with aortic valve disease? (abstract). J Am Soc Echocardiogr 2001;14:452.
12. Chan KL, Ghani M, Woodend K, Burwash IG: Case-controlled study to assess risk factors for aortic stenosis in congenitally bicuspid aortic valve. Am J Cardiol 2001;88:690-693.
13. Deutscher S, Rockette HE, Krishnaswami V: Diabetes and hypercholesterolemia among patients with calcific aortic stenosis. J Chronic Dis 1984;37:407-415.
14. Aronow WS, Schwartz KS, Koenigsberg M: Correlation of serum lipids, calcium and phosphorus, diabetes mellitus, aortic valve stenosis and history of systemic hypertension with presence or absence of mitral anular calcium in persons older than 62 years in a long-term health care facility. Am J Cardiol 1987;59:381-382.
15. Boon A, Cheriex E, Lodder J, Kessels F: Cardiac valve calcification: Characteristics of patients with calcification of the mitral annulus or aortic valve. Heart 1997;78:472-474.
16. Wihnshurst PT, Stevenson RN, Griffiths H, Lord JR: A case-control investigation of the relation between hyperlipidaemia and calcific aortic valve stenosis. Heart 1997;78:475-479.
17. He GW, Acuff TE, Ryan WH, Douthit MB, Bowman RT, He YH, Mack MJ: Aortic valve replacement: Determinants of operative mortality. Ann Thorac Surg 1994;57:1140-1146.
18. Lund O, Nielsen TT, Pilegaard HK, Magnussen K, Knudsen MA: The influence of coronary artery disease and bypass grafting on early and late survival after valve replacement for aortic stenosis. J Thorac Cardiovasc Surg 1990;100:327-337.
19. Stampfer MJ, Malinow MR, Willett WC, Newcomer LM, Upson B, Ullmann D, Tishler PV, Hennekens CH: A prospective study of plasma homocysteine and risk of myocardial infarction in US physicians. JAMA 1992;268:877-881.
20. Nygard O, Nordrehaug JE, Refsum H, Ueland PM, Farstad M, Vollset SK: Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med 1997;337:230-236.
21. Blacher J, Montalescot G, Ankri A, Chadefaux-Vekemans B, Benzidia R, Grosgogeat Y, Kamoun P, Thomas D: Homocysteinemia in coronary artery disease: Results of study of 102 patients. Arch Mal Coeur Vaiss 1996;89:1241-1246.
22. Mayer H, Jacobsen DW, Robinson K: Homocysteine and coronary atherosclerosis. J Am Coll Cardiol 1996;27:517-527.